Clinical Trial Update: A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial to compare odronextamab plus chemotherapy versus rituximab plus chemotherapy in adults with follicular lymphoma to assess safety, tolerability, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Odronextamab (odronextamab)
• Rituximab (rituximab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Follicular Lymphoma (FL) | Phase 3 | Status: ACTIVE_NOT_RECRUITING